17-41990351-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003315.4(DNAJC7):c.512T>A(p.Phe171Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,611,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003315.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJC7 | NM_003315.4 | c.512T>A | p.Phe171Tyr | missense_variant | 6/14 | ENST00000457167.9 | NP_003306.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJC7 | ENST00000457167.9 | c.512T>A | p.Phe171Tyr | missense_variant | 6/14 | 1 | NM_003315.4 | ENSP00000406463.2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000164 AC: 4AN: 244158Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132400
GnomAD4 exome AF: 0.00000823 AC: 12AN: 1458848Hom.: 0 Cov.: 31 AF XY: 0.00000827 AC XY: 6AN XY: 725332
GnomAD4 genome AF: 0.000118 AC: 18AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 17, 2023 | The c.512T>A (p.F171Y) alteration is located in exon 6 (coding exon 6) of the DNAJC7 gene. This alteration results from a T to A substitution at nucleotide position 512, causing the phenylalanine (F) at amino acid position 171 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at